VECT
Price:
$16.87
Market Cap:
$1.06B
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for SBS-IF in patients with colon-in-continuity anatomy. The company is also developing apraglutide, which is in Phase II clinical trial for patients with steroid-refractory gastrointestinal acute versus host disease (aGvHD). The company was incorporate...[Read more]
Industry
Biotechnology
IPO Date
2021-04-08
Stock Exchange
NASDAQ
Ticker
VECT
According to VectivBio Holding AG’s latest financial reports and current stock price. The company's current Current Ratio is 9.14. This represents a change of 80.74% compared to the average of 5.06 of the last 4 quarters.
The mean historical Current Ratio of VectivBio Holding AG over the last ten years is 4.32. The current 9.14 Current Ratio has changed 21.06% with respect to the historical average. Over the past ten years (40 quarters), VECT's Current Ratio was at its highest in in the December 2022 quarter at 9.14. The Current Ratio was at its lowest in in the April 2023 quarter at 0.
Average
4.32
Median
4.04
Minimum
0.65
Maximum
9.14
Discovering the peaks and valleys of VectivBio Holding AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 368.31%
Maximum Annual Current Ratio = 9.14
Minimum Annual Increase = -83.90%
Minimum Annual Current Ratio = 0.65
Year | Current Ratio | Change |
---|---|---|
2022 | 9.14 | 42.73% |
2021 | 6.41 | 368.31% |
2020 | 1.37 | 110.21% |
2019 | 0.65 | -83.90% |
The current Current Ratio of VectivBio Holding AG (VECT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.64
5-year avg
4.32
10-year avg
4.32
VectivBio Holding AG’s Current Ratio is greater than CNS Pharmaceuticals, Inc. (1.82), greater than ZyVersa Therapeutics, Inc. (0.03), greater than eFFECTOR Therapeutics, Inc. (1.03), less than AVROBIO, Inc. (26.17), greater than Immix Biopharma, Inc. (3.47), greater than Hepion Pharmaceuticals, Inc. (1.30), less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.03), greater than Enveric Biosciences, Inc. (5.17), less than Elevation Oncology, Inc. (17.77), less than Zura Bio Limited (10.36),
Company | Current Ratio | Market cap |
---|---|---|
1.82 | $7.15M | |
0.03 | $2.65M | |
1.03 | $941.00 | |
26.17 | $5.24M | |
3.47 | $49.14M | |
1.30 | $4.62M | |
15.69 | $1.45M | |
0.03 | $24.95M | |
5.17 | $3.31M | |
17.77 | $35.67M | |
10.36 | $178.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VectivBio Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VectivBio Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is VectivBio Holding AG's Current Ratio?
How is the Current Ratio calculated for VectivBio Holding AG (VECT)?
What is the highest Current Ratio for VectivBio Holding AG (VECT)?
What is the 3-year average Current Ratio for VectivBio Holding AG (VECT)?
What is the 5-year average Current Ratio for VectivBio Holding AG (VECT)?
How does the current Current Ratio for VectivBio Holding AG (VECT) compare to its historical average?